Develops engineered enzymes used in pharmaceutical manufacturing, food production, and other industrial processes through a proprietary protein engineering platform. The company partners with drugmakers and research organizations to supply biocatalysts that improve the efficiency of complex chemical...
1 member of Congress has disclosed 1 trade in Codexis, Inc. (CDXS), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-04-06 | Lamar Smith | buy | $1K – $15K |